Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines

Vaccine

Volumn 27, Issue 21, 2009, Pages 2768-2774

  Potthoff, A ^a   Schwannecke, S ^a   Nabi, G ^a   Hoffmann, D ^a   Grunwald, T ^a   Wildner, O ^a   Brockmeyer, N H ^a   Uberla K ^a   Tenbusch, M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adenoviral vectors; Intradermal vaccination; Tattooing

Indexed keywords

ADENOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TATTOO;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; CELL LINE; FEMALE; GENETIC VECTORS; IMMUNIZATION; IMMUNOGENETICS; INJECTIONS, INTRADERMAL; MICE; MODELS, IMMUNOLOGICAL; TATTOOING; VIRAL VACCINES;

EID: 64449087614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.001     Document Type: Article

References (32)

1. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldrigde R.L., et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407 September (6803) (2000) 523-526
2. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189 March (6) (1999) 991-998
3. McMichael A.J. HIV vaccines. Annu Rev Immunol 24 (2006) 227-255
4. Shott J.P., McGrath S.M., Pau M.G., Custers J.H.V., Ophorst O., Demoiti M.A., et al. Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-[gamma] and antibody responses in mice. Vaccine 26 June (23) (2008) 2818-2823
5. Rodrigues E.G., Zavala F., Nussenzweig R.S., Wilson J.M., and Tsuji M. Efficient induction of protective anti-malaria immunity by recombinant adenovirus. Vaccine 16 November (19) (1998) 1812-1817
6. Holman D.H., Wang D., Raja N.U., Luo M., Moore K.M., Woraratanadharm J., et al. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 26 May (21) (2008) 2627-2639
7. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 January (6869) (2002) 331-335
8. Barouch D.H., Pau M.G., Custers J.H., Koudstaal W., Kostense S., Havenga M.J., et al. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol 172 May (10) (2004) 6290-6297
9. Liu J., Ewald B.A., Lynch D.M., Denholtz M., Abbink P., Lemckert A.A., et al. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J Virol 82 May (10) (2008) 4844-4852
10. Buchbinder S.P., Mehrotra D.V., Duerr A., Fitzgerald D.W., Mogg R., Li D., et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372 November (9653) (2008) 1881-1893
11. McElrath M.J., De Rosa S.C., Moodie Z., Dubey S., Kierstead L., Janes H., et al. HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis. Lancet 372 November (9653) (2008) 1894-1905
12. Sekaly R.P. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. J Exp Med 205 January (1) (2008) 7-12
13. Liu J., Kjeken R., Mathiesen I., and Barouch D.H. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol 82 June (11) (2008) 5643-5649
14. Bachy M., Boudet F., Bureau M., Girerd-Chambaz Y., Wils P., Scherman D., et al. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine 19 February (13-14) (2001) 1688-1693
15. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 May (9) (2000) 4635-4640
16. Bins A.D., Jorritsma A., Wolkers M.C., Hung C.F., Wu T.C., Schumacher T.N., et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11 August (8) (2005) 899-904
17. Pokorna D., Rubio I., and Muller M. DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther 6 (2008) 4
18. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., et al. Dendritic cell subsets in health and disease. Immunol Rev 219 October (2007) 118-142
19. Sugita K., Kabashima K., Atarashi K., Shimauchi T., Kobayashi M., and Tokura Y. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 147 January (1) (2007) 176-183
20. Gopee N.V., Cui Y., Olson G., Warbritton A.R., Miller B.J., Couch L.H., et al. Response of mouse skin to tattooing: use of SKH-1 mice as a surrogate model for human tattooing. Toxicol Appl Pharmacol 209 December (2) (2005) 145-158
21. Verstrepen B.E., Bins A.D., Rollier C.S., Mooij P., Koopman G., Sheppard N.C., et al. Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 26 June (26) (2008) 3346-3351
22. Tenbusch M., Kuate S., Tippler B., Gerlach N., Schimmer S., Dittmer U., et al. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity. BMC Immunol 9 (2008) 13
23. Stahl-Hennig C., Kuate S., Franz M., Suh Y.S., Stoiber H., Sauermann U., et al. Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J Virol 81 December (23) (2007) 13180-13190
24. Kuate S., Stefanou D., Hoffmann D., Wildner O., and Uberla K. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses. J Gene Med 6 November (11) (2004) 1197-1205
25. Hoffmann D., Meyer B., and Wildner O. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses. J Gene Med 9 September (9) (2007) 764-778
26. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95 March (5) (1998) 2509-2514
27. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 October (1-2) (2003) 65-78
28. Ternette N., Tippler B., Überla K., and Grunwald T. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine 25 October (41) (2007) 7271-7279
29. Hallak L.K., Collins P.L., Knudson W., and Peeples M.E. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271 June (2) (2000) 264-275
30. Muruve D.A. The innate immune response to adenovirus vectors. Hum Gene Ther 15 12 (2004) 1157-1166
31. Zhu J., Huang X., and Yang Y. Innate immune response to adenoviral vectors is mediated by both toll-like receptor-dependent and -independent pathways. J Virol 81 April (7) (2007) 3170-3180
32. Dai Y., Schwarz E.M., Gu D., Zhang W.W., Sarvetnick N., and Verma I.M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 92 February (5) (1995) 1401-1405